These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 3306546)
21. [Comparison of the effectiveness and safety of levobunolol and timolol in ocular hypertension and chronic open-angle glaucoma]. Freyler H; Novack GD; Menapace R; Skorpik C; Mordaunt J; Batoosingh AL Klin Monbl Augenheilkd; 1988 Sep; 193(3):257-60. PubMed ID: 3070134 [TBL] [Abstract][Full Text] [Related]
22. A comparison of the efficacy and tolerability of 0.5% timolol maleate ophthalmic gel-forming solution QD and 0.5% levobunolol hydrochloride BID in patients with ocular hypertension or open-angle glaucoma. Halper LK; Johnson-Pratt L; Dobbins T; Hartenbaum D J Ocul Pharmacol Ther; 2002 Apr; 18(2):105-13. PubMed ID: 12002664 [TBL] [Abstract][Full Text] [Related]
23. [Local subjective tolerance of levobunolol and metipranolol in a double-blind comparative study in patients with increased intraocular pressure]. Ober M; Scharrer A; Novack GD; Lue JC Ophthalmologica; 1986; 192(3):159-64. PubMed ID: 2873545 [TBL] [Abstract][Full Text] [Related]
24. The effect of topical beta-adrenoceptor blocking agents on pulsatile ocular blood flow. Morsman CD; Bosem ME; Lusky M; Weinreb RN Eye (Lond); 1995; 9 ( Pt 3)():344-7. PubMed ID: 7556745 [TBL] [Abstract][Full Text] [Related]
25. Levobunolol for the long-term treatment of glaucoma. Novack GD Gen Pharmacol; 1986; 17(4):373-7. PubMed ID: 3019819 [TBL] [Abstract][Full Text] [Related]
26. Effects of topical latanoprost on optic nerve head circulation in rabbits, monkeys, and humans. Ishii K; Tomidokoro A; Nagahara M; Tamaki Y; Kanno M; Fukaya Y; Araie M Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2957-63. PubMed ID: 11687542 [TBL] [Abstract][Full Text] [Related]
27. Topical verapamil and episcleral venous pressure. Abreu MM; Kim YY; Shin DH; Netland PA Ophthalmology; 1998 Dec; 105(12):2251-5. PubMed ID: 9855155 [TBL] [Abstract][Full Text] [Related]
28. Ocular hypotensive safety and systemic absorption of AR-13324 ophthalmic solution in normal volunteers. Levy B; Ramirez N; Novack GD; Kopczynski C Am J Ophthalmol; 2015 May; 159(5):980-5.e1. PubMed ID: 25637177 [TBL] [Abstract][Full Text] [Related]
29. [Vistagan-Liquifilm in the treatment of simple glaucoma]. Szymankiewiczowa S Klin Oczna; 1989 Jun; 91(6):163-4. PubMed ID: 2576678 [TBL] [Abstract][Full Text] [Related]
30. Betaxolol and levobunolol: new beta-blocking antiglaucoma agents. Tierney DW J Am Optom Assoc; 1987 Sep; 58(9):722-7. PubMed ID: 2895783 [TBL] [Abstract][Full Text] [Related]
31. [Hypersensitivity to levobunolol]. Schultheiss E Derm Beruf Umwelt; 1989; 37(5):185-6. PubMed ID: 2530078 [TBL] [Abstract][Full Text] [Related]
32. Local effect of topical FP-receptor agonists on retinal vessels of the ipsilateral posterior retina in normal rabbit eyes. Ohashi M; Mayama C; Ishi K; Araie M Clin Exp Ophthalmol; 2008 Nov; 36(8):767-74. PubMed ID: 19128383 [TBL] [Abstract][Full Text] [Related]
33. Intraocular pressure-lowering effects and safety of topical administration of a selective ROCK inhibitor, SNJ-1656, in healthy volunteers. Tanihara H; Inatani M; Honjo M; Tokushige H; Azuma J; Araie M Arch Ophthalmol; 2008 Mar; 126(3):309-15. PubMed ID: 18332309 [TBL] [Abstract][Full Text] [Related]
34. Topically applied levobunolol does not cause changes in the corneal endothelium. Fusco R; Del Prete A; Gravina A; Nieto G Doc Ophthalmol; 1990-1991; 76(3):273-7. PubMed ID: 2103529 [TBL] [Abstract][Full Text] [Related]
35. Is it worthwhile to add dipivefrin HCl 0.1% to topical beta 1-, beta 2-blocker therapy? Parrow KA; Hong YJ; Shin DH; Shi DX; McCarty B Ophthalmology; 1989 Sep; 96(9):1338-41; discussion 1341-2. PubMed ID: 2571114 [TBL] [Abstract][Full Text] [Related]
36. Intraocular pressure after a two-week washout following long-term timolol or levobunolol. Hong YJ; Shin DH; Ahn BH; McCarty B J Ocul Pharmacol Ther; 1995; 11(2):107-12. PubMed ID: 8564631 [TBL] [Abstract][Full Text] [Related]
37. Topical latanoprost and optic nerve head and retinal circulation in humans. Tamaki Y; Nagahara M; Araie M; Tomita K; Sandoh S; Tomidokoro A J Ocul Pharmacol Ther; 2001 Oct; 17(5):403-11. PubMed ID: 11765145 [TBL] [Abstract][Full Text] [Related]
38. Levobunolol compared with timolol for the control of elevated intraocular pressure. Geyer O; Lazar M; Novack GD; Lue JC; Duzman E Ann Ophthalmol; 1986 Oct; 18(10):289-90, 292. PubMed ID: 3535611 [TBL] [Abstract][Full Text] [Related]
39. Adverse drugs reactions associated with glaucoma medications. Reyes E; Izquierdo NJ; Blasini M Bol Asoc Med P R; 1997; 89(4-6):51-5. PubMed ID: 9284599 [TBL] [Abstract][Full Text] [Related]
40. A correlation between latanoprost-induced conjunctival hyperemia and intraocular pressure-lowering effect. Kobayashi H; Kobayashi K J Glaucoma; 2011 Jan; 20(1):3-6. PubMed ID: 20520573 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]